Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology VC (Venture Capital) Funds in China in October 2024

Last updated: Oct 2024 A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in China. We rank investors based on the number of investments they made in Biotechnology companies from China. We update this investor list every month.

Top 50 Biotechnology VC (Venture Capital) Funds in China in October 2024

Investor	Biotechnology China investments
Qiming Venture Partners	47
HongShan	39
Med-Fine Capital	25
Lilly Asia Ventures	24
Kaitai Capital	22
IDG Capital	19
Sherpa Healthcare Partners	18
Northern Light Venture Capital	18
Frees Fund	18
Hillhouse Investment	17
Legend Capital	17
BioVenture	17
CDH Investments	15
TF Capital	15
Highlight Capital	14
Green Pine Capital Partners	12
LYFE Capital	11
BioTrack Capital	11
Cowin Venture	11
Addor Capital	11
Puhua Capital	11
Cowin Capital	11
CD Capital	10
K2VC	10
Redhill Capital	9
Linear Capital	9
ZhenFund	9
Huagai Capital	9
SDIC Venture Capital	9
Gaorong Capital	9
Lucion	8
Oriental Fortune Capital	8
EFung Capital	8
Oriza Holdings	8
Baidu Ventures	8
ARCH Venture Partners	8
Sinovation Ventures	8
Goldport Capital	8
Lapam Capital	8
Shenzhen Capital Group	8
Volcanics Venture	8
Source Code Capital	8
CASH Capital	8
Legend Star	8
Sinopharm Capital	7
Delian Capital	7
Sky9 Capital	7
OrbiMed	7
GL Ventures LLC	7
3E Bioventures	7

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

We help founders build enduring companies.

Investment focus

Biotechnology, Health Care, Artificial Intelligence
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
Sanshou Technology — Sanshou Technology focuses on researching and developing smart motorcycles.
RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Targeting One — Targeting One is an in-vitro diagnostic product developer.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Angel, Seed
China, United States

Portfolio highlights

Huaboron Neutron — Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.
Nafi Pharmaceuticals — Nafi Pharmaceuticals develops novel medications for central nervous system illnesses.
Atom Bioscience & Pharmaceutical — Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Sentient — Community-built open AGI
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Biotechnology, Medical
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Polycent — Polycent, a technology company with expertise in power technology, industrial control, data intelligence, and FPGA, develops digital power solutions using advanced electrical, sensing, and algorithm technologies, accelerating industrialization and high-quality power system development.
Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
Hangkai Microelectronics — Hangkai MicroTech focuses on the research, development, and manufacturing of Mems technology and products, with an emphasis on the demand for domestic sensor substitutes.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Yida Technology — SaaS, Data
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Seed
China, United States

Portfolio highlights

AskGene Pharma — AskGene Pharma is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. Learn about our SmartKine platform.
Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.

Green Pine Capital Partners is a venture capital firm.

Investment focus

Artificial Intelligence, Manufacturing, Software
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.

In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
China, United States, France

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Investment focus

Health Care, Biotechnology, Medical
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Xingmu — Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses.
ZWI Therapeutics, Inc. — ZWI Therapeutics biotech therapeutics polymer
Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Series B, Funding Round
China, Hong Kong, United States

Portfolio highlights

Arthur Pharmaceuticals — Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer.
Quail Fire Optoelectronics — Quailhuo Photovoltaic is a provider of solar power generation technology, specializing in the design and development of perovskite photovoltaic materials and battery component preparation technology.
Suzhou Shensai New Materials — Suzhou Shensai New Materials manufacturers environmentally friendly clean foaming materials and other lightweight materials.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United Kingdom, United States

Portfolio highlights

Glbizzia — Glbizzia is a company specializing in genetic testing, data utilization, and biological breeding platforms, focusing on high-throughput omics big data analysis, intelligent omics experiments, and scientific research consulting.
Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
ICleague Technology — ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption.

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
Feiduwei — Feiduwei specializes in researching and developing mixed digital and analog circuits, including signal chain and power-related chips.The devices are utilized in automotive electronics, industrial control, consumer electronics, and various other applications.
Xingchen Optoelectronics — Xingchen Optoelectronics is dedicated to pushing the boundaries of existing laser communication payload solutions and fostering the development of high-speed satellite laser communication networks.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Investment focus

E-Commerce, Manufacturing, Health Care
Series A, Seed, Angel
China, United States, Japan

Portfolio highlights

Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Ligu Renewable Energy — Ligu Renewable Energy is a renewable energy company that provides organic liquid hydrogen storage, transportation, and renewable solutions.

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China

Portfolio highlights

Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
Inflamax Pharmaceuticals — Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.
EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.

Linear Capital focuses on investment projects in the fields of Data Application, Data Infrastructure and cutting-edge technology applications. they believe that cutting-edge technology is the primary productive force, and they are committed to becoming an important promoter of cutting-edge technology landing industries, realizing FrontierTechnology,

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Series A
China, Germany, Hong Kong

Portfolio highlights

Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
Green Carbon Synthesis — Green Carbon Synthesis is a process developer for green fuel production, focusing on sustainable aviation fuel, biodiesel, and bio-naphtha, using Fischer-Tropsch synthesis technology.

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Investment focus

Artificial Intelligence, Software, E-Commerce
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

UXLINK — UXLINK is a social infrastructure comprised of social protocols and a collection of Dapps.UXLINk creates groundbreaking landing sceneries for web3 groups.
MioTech — MioTech is an artificial intelligence platform that empowers investment managers to better serve their clients in a world of complex data. By integrating and analyzing data from all types of sources, MioTech streamlines the entire investment process, creating an ultimate data-driven investing experience. MioTech has offices in Shanghai and HongKong.MioTech is backed by Horizons Ventures, ZhenFund, and prestigious individual investors around the world.
Yi'an Holdings — Yi'an Holdings is a financial services company that provides one-stop investment banking services to small and medium-sized companies.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

Investment focus

Manufacturing, Biotechnology, Health Care
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Kaihong Digital — Kaihong Digital is an IoT operating system developer which focuses on developing IoT operating systems. The company's business model combines AloT operating system consultancy, R&D, customisation, delivery, and after-sales services to provide users with pan-intelligent terminal operating system technology and products.
Noding Intelligence — Noding Intelligence is a pan-semiconductor testing equipment R&D and manufacturing company.
Taihe Petrochemical — Taihe Petrochemical is a fluid control, industrial process solutions, and fluid technology consulting company that provides research and development, design, production, sales, and technical services for valves, pipe fittings, and other products.

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.

Investment focus

Information Technology, E-Commerce, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Series B, Seed
China

Portfolio highlights

Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
ThunderBio Innovation — ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
Xinshi Technology — Xinshi Technology is the developer of semiconductor front-end measurement and testing equipment.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.

"BV is an independent venture fund established by Baidu in 2017. BV's investors include Baidu as well as other leading financial institutions and businesses. BV currently manages roughly $500M USD across 3 funds and has offices in Beijing and San Francisco. Its mission is to support entrepreneurs and companies who are spearheading the newage of artificial intelligence. These companies are changing the way we work and live—and ultimately how we interact."

Investment focus

Artificial Intelligence, Health Care, Biotechnology
Series A, Seed, Series B
China, United States, Germany

Portfolio highlights

UDEER.AI — UDEER.AI is a robotics company that focuses on embodied intelligence technology and specializes in the development of universal brains for robots.
Huayi Quantum — Huayi Quantum is a quantum computer and quantum cloud platform developer specializing in advanced algorithm research and application acceleration.The business creates modular, standardized, and scalable quantum computers based on ion-trap technology.
Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, China, United Kingdom

Portfolio highlights

Vilya — Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology.
Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
Rippl Care — Dementia care for seniors, ready when you are

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Investment focus

Software, Artificial Intelligence, Internet
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Biopharma
Series A, Seed, Angel
China

Portfolio highlights

Fast Photonics — Fast Photonics specializes in the development and manufacturing of high-speed optical transceivers. The company offers a range of products designed for various applications in the field of optical communication. With a focus on innovation, Fast Photonics aims to provide solutions that meet the evolving needs of data transmission and communicationnetworks. The company holds ISO certification, emphasizing its commitment to quality and standards in manufacturing processes. Fast Photonics serves as an OEM/ODM/JDM partner, offering customized solutions to meet specific customer requirements. The company's expertise in optical technology makes it a key player in the industry, catering to the demands for faster and more efficient data communication.
REEM Healthcare — REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medicaldevices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.
Ruigu New Materials — Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.

Lapam Capital is a healthcare-focused venture capital firm.

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series B, Series A, Series C
China, United States

Portfolio highlights

Deyun Kangrui — Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&D and the production of full-chain single-cell multi-omics technology.
LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
Guangdong Xinyue — Xinyueneng manufactures silicon carbide chips and conducts research and development in the automotive and industrial control industries.
Aerospace China Electronics — Aerospace China Electronics is a chip solution vendor that serves the military and civilian industries for Internet of Things connectivity, security, and terminal intelligence.

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Seed
China, United States

Portfolio highlights

Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

Investment focus

Software, E-Commerce, Artificial Intelligence
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
Zhihe Computing — Zhihe Computing is an AI intelligent computing company that develops high-performance, scalable AI intelligent computing CPUs and RISC-V processors.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.

Investment focus

Health Care, Biotechnology, Manufacturing
Series A, Series B, Series C
China, United States

Portfolio highlights

Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Investment focus

Health Care, Medical, Biotechnology
Series A, Angel, Seed
China, United States, France

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.

Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Canada

Portfolio highlights

Xishan — Xishan is a surgical equipment and consumables manufacturing company.
Metanovas — Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
Artivila Therapeutics — Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.

Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Series B, Seed
China, United States, France

Portfolio highlights

PulseCare — PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
Reju Therapeutics — Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.
Yitai Microelectronics — Yitai Microelectronics is an automotive Ethernet chip developer company that specializes on producing high-performance, high-reliability, and low-power automotive Ethernet communication chips and systems.

Sky9 Capital is a leading venture capital fund dedicated to supporting disruptive technologies and outstanding innovators to drive change and create positive impact for society, the environment and individual lives. Sky9 Capital team includes senior experts, entrepreneurs, and experienced investors from diverse backgrounds. Since 2011, the team hasmanaged a number of USD and RMB funds, whose total assets under management of nearly USD 2 billion.

Investment focus

Software, Blockchain, Information Technology
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

SnakeLite — Snake Lite is a classic arcade snake game with a competitive edge and offers offline and online play. It is designed for smooth controls and fast performance.
Zhihe Computing — Zhihe Computing is an AI intelligent computing company that develops high-performance, scalable AI intelligent computing CPUs and RISC-V processors.
Sentient Labs — Creatify is a minimalist, dark-themed Webflow template designed specifically for design agencies and creative studios. It features a timeless design, subtle animations, a fully functioning CMS, and everything you need to elevate your online presence to the next level.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Chemomab — Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases
MBX Biosciences — Homepage - MBX Biosciences
Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.

GL Ventures LLC is a venture capital affiliate of Hillhouse.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, Hong Kong, United States

Portfolio highlights

LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Mingyang Hydrogen Energy — Mingyang Hydrogen Energy is a company that develops, manufactures, and distributes high-performance hydrogen production electrolyzer devices. It is dedicated to creating a green hydrogen "production, storage, and use" scenario that combines "light, storage, and hydrogen."
Suqian Times Energy Storage — Suqian Times Energy Storage is a manufacturer of flow energy storage batteries. It is an innovative business that specializes in the study, development, and manufacture of aqueous organic flow energy storage batteries

3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years of successful investment or entrepreneurship experience in China. The 3E team combines good global industry perspectives with practical on the ground Chinaexperiences, the team’s past investment portfolio companies cover areas such as drug, device, diagnostics, healthcare IT and medical services. 3E Bioventures Capital currently manages both RMB and US Dollar funds, investing in early and growing stage companies in China and overseas. They believe in the huge industry growth and significant investment opportunities in China healthcare space for the next 10 to 20 years. They aim to leverage their healthcare expertise and experience to ride this historic opportunity, to help build successful healthcare ventures and technologies, to generate good return for their investors, and at the same time, to build 3E Bioventures into a significant international healthcare investment brand.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States

Portfolio highlights

Cellbri — Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs.
Tianhu Technology — Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Investors by industry

Artificial intelligence